CI

At a glance

ClinicalIndex Comparison Record
N/ACompleted
Drug / intervention
dextromethorphan +2 moredrug
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.

Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.

Search/NCT00004807
NCT00004807N/ACompleted

Study of the Pathogenesis of Rett Syndrome

Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD)·interventional·Posted Feb 25, 2000·Updated Jun 24, 2005

In Brief

A clinical study evaluating dextromethorphan, topiramate, and 1 other intervention for Rett Syndrome. Completed.

Detailed Summary

OBJECTIVES: I. Extend current knowledge of the phenotype and natural history of Rett syndrome (RS). II. Continue the search for a cytogenetic and/or DNA marker. III. Study the effects of cholinergic drugs based on preliminary evidence for reduced levels of brain acetylcholine, while continuing supportive care to modify seizures, respiratory abnormalities, and motor disturbances, and improve nutrition, behavior, and learning. IV. Identify targets for future therapeutic interventions, e.g., growth factors, to influence neurologic recovery.

Study Details

Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
ConditionsRett Syndrome
Countries--

Timeline

N/ACompletedFinished
199519961997199819992000200120022003200420052006200720082009201020112012201320142015201620172018201920202021202220232024202520262027
First PostedFeb 25, 2000
Enrollment StartJan 1, 1995
TodayJul 2, 2026
Posted 26.4 years ago

Interventions

dextromethorphandrug

topiramatedrug

Donepezildrug